Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has received an average rating of “Buy” from the nine analysts that are presently covering the firm, Marketbeat.com reports. One research analyst ...
Some results have been hidden because they may be inaccessible to you